ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis
Trial details
- Registry ID
- NCT07090330
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque PsoriasisNCT07090330 | ORKA | Phase 2 | Active not recruiting | 2026-03-25Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |